RSNA: Bariatric embolization is safe and well tolerated in morbidly obese individuals.
The procedure reduces the stomach’s production of ghrelin, a potent hunger-stimulating hormone.
Patients experienced an average weight loss of 5.9 percent at one month and 9.0 percent at three months.
A novel interventional radiology technique for weight loss is safe
and well tolerated in morbidly obese individuals, according to a new
study appearing in the online edition of
Radiology. Though the results are preliminary, the technique has the potential to be a new weapon in the war on obesity.
